Literature DB >> 20495083

The role of radiation therapy in the treatment of medullary thyroid cancer.

Stephanie A Terezakis1, Nancy Y Lee.   

Abstract

Medullary thyroid cancer (MTC) is a neuroendocrine tumor derived from parafollicular or C cells of the thyroid gland. Surgical resection is the mainstay of treatment for MTC. External-beam radiation treatment (EBRT) has traditionally played a limited role in the management of MTC. Despite aggressive surgery, patients at high risk for local recurrence may benefit from adjuvant EBRT. With improvements in radiation technique, adequate dose can be effectively delivered to the region at risk while minimizing dose to surrounding critical structures. Although the role of EBRT in the management of these tumors has thus far been poorly defined, EBRT should be considered as a treatment option for patients with locally advanced MTC to optimize locoregional control.

Entities:  

Mesh:

Year:  2010        PMID: 20495083     DOI: 10.6004/jnccn.2010.0041

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  8 in total

Review 1.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm.

Authors:  Barbara Jarzab; Jolanta Krajewska
Journal:  Eur Endocrinol       Date:  2014-08-28

4.  Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.

Authors:  Anish Jacob Cherian; Pooja Ramakant; Rekha Pai; Marie Therese Manipadam; S Elanthenral; Anuradha Chandramohan; Julie Hephzibah; David Mathew; Dhukabandhu Naik; Thomas V Paul; Simon Rajaratnam; Nihal Thomas; M J Paul; Deepak Thomas Abraham
Journal:  Indian J Surg Oncol       Date:  2017-12-08

5.  Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.

Authors:  Thomas H Beckham; Paul B Romesser; Andries H Groen; Christopher Sabol; Ashok R Shaha; Mona Sabra; Thomas Brinkman; Daniel Spielsinger; Sean McBride; C Jillian Tsai; Nadeem Riaz; R Michael Tuttle; James A Fagin; Eric J Sherman; Richard J Wong; Nancy Y Lee
Journal:  Thyroid       Date:  2018-09       Impact factor: 6.568

6.  Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature.

Authors:  Christopher Munoz-Bendix; Antonio Santacroce; Kristin Gierga; Frank W Floeth; Hans-Jakob Steiger; Marco Antonio Penalonzo; Sven Oliver Eicker
Journal:  Clin Case Rep       Date:  2015-11-09

7.  Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

Authors:  Vishnu Muthuraj Kumarasamy; Daekyu Sun
Journal:  Int J Oncol       Date:  2017-05-11       Impact factor: 5.650

8.  The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma.

Authors:  Aleksandra Kukulska; Jolanta Krajewska; Zofia Kolosza; Ewa Paliczka-Cieslik; Aleksandra Kropinska; Agnieszka Pawlaczek; Zbigniew Puch; Kornelia Ficek; Teresa Lisik; Dorota Sygula; Zbigniew Wygoda; Jozef Roskosz; Jerzy Wydmanski; Barbara Jarzab
Journal:  Endocr Connect       Date:  2019-11-01       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.